Ingevity (NGVT) Capital Expenditures (2015 - 2026)

Ingevity (NGVT) has 12 years of Capital Expenditures data on file, last reported at $10.3 million in Q1 2026.

• Quarterly Capital Expenditures rose 255.17% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (up 1.39% YoY) and the FY2025 annual result came in at $1.7 million, down 29.17% from the prior year.
• Capital Expenditures rose to $10.3 million in Q1 2026 per NGVT's latest filing, from $100000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $51.9 million in Q2 2022 and bottomed at -$52.1 million in Q3 2022.
• The 5-year median for Capital Expenditures is $10.3 million (2026), against an average of $10.3 million.
• The widest annual swing landed in 2022, when Capital Expenditures slumped 1960.71%; it then soared 14700.0% in 2023.
• Tracing NGVT's Capital Expenditures over 5 years: stood at -$200000.0 in 2022, then soared by 14700.0% to $29.2 million in 2023, then plunged by 99.32% to $200000.0 in 2024, then tumbled by 50.0% to $100000.0 in 2025, then soared by 10200.0% to $10.3 million in 2026.
• Per Business Quant, the three latest NGVT Capital Expenditures figures stand at $10.3 million (Q1 2026), $100000.0 (Q4 2025), and -$700000.0 (Q3 2025).

Peer Comparison